Today

Agents

Chat

Arena

Discover

More

App

Vir Biotechnology Q2 EPS USD 0.48 - VIR News | Rallies

Vir Biotechnology Q2 EPS USD 0.48

VIR•2026-08-05

Vir Biotechnology reports second-quarter results

Aug. 5 (Reuters) - Vir Biotechnology Q2 revenue USD 238.9 million vs. IBES estimate USD 216.5 million.

Q2 net income USD 80.1 million

Related News

Arcus Biosciences Q2 revenue falls sharply on lower license income

RCUS•2026-08-05

PacBio Q2 FY26 net loss widens to $44.7 million; revenue slips 2% to $39 million

PACB•2026-08-05

OraSure Q2 revenue rises on higher diagnostics sales

OSUR•2026-08-05

S

Solventum plans separation of Health Information Systems unit

SOLV•2026-08-05

Digi International Q3 revenue beats estimates on increased demand, acquisition contributions

DGII•2026-08-05